不同Child-Pugh分级的血吸虫病性肝硬化患者肝脏CT灌注成像参数分析

doi:10.3969/j.issn.1672-5069.2020.05.022

摘要/Abstract

摘要： 目的探讨不同Child-Pugh分级的血吸虫病性肝硬化患者肝脏CT灌注成像参数的变化。方法 2016年5月～2018年10月我院诊治的血吸虫病性肝硬化患者40例(Child A级12例,B级16例和C级12例)和同期健康人40例,接受螺旋CT检查,应用 CT Perfusion 4D肝脏灌注软件包处理肝脏灌注的相关数据,包括平均通过时间(MTT)、肝动脉分数(HAF)、肝动脉灌注量(HAP)、血容量(BV)和肝血流量(BF)等参数。结果健康人肝脏CT检测的BV、BF、MTT、HAF和HAP分别为(45.7±8.4)mL/100g、(212.6±43.3)mL/min·100g、(13.5±2.3) s、(0.2±0.0)和(16.3±8.3)mL/min·100g,而Child A级患者分别为(41.0±15.3)mL/100g、(185.6±38.4)mL/min·100g、(15.2±1.2) s、(0.2±0.0)和(20.5±8.0)mL/min·100g,Child B级分别为(38.5±20.6)mL/100g、(126.6±90.5)mL/min·100g、(19.4±11.4) s、(0.3±0.0)和(26.7±2.0)mL/min·100g,Child C级分别为(23.3±8.7)mL/100g、(129.4±46.6)mL/min·100g、(27.5±2.7) s、(0.4±0.1)和(35.2±12.6)mL/min·100g,肝硬化与健康人及不同Child分级的肝硬化患者之间,差异显著(P<0.05)。结论血吸虫病性肝硬化肝脏CT检查能提供形态学改变信息,CT灌注成像参数可以较好地评估肝硬化程度。

关键词: 血吸虫病性肝硬化, Child-Pugh分级, 多层螺旋CT, 灌注成像, 血流参数 , ,

Abstract: Objective The aim of this study was to analyse the CT liver perfusion imaging parameters in patients with schistosomiasis-induced liver cirrhosis. Methods 40 patients with schistosomiasis-induced liver cirrhosis (Child A in 12, B in 16 and C in 12) and 40 healthy persons were recruited in our hospital between May 2016 and October 2018, and all of them underwent liver perfusion of spiral CT scanning. The blood volume (BV), blood flow (BF) , mean transit time (MTT), hepatic artery fraction (HAF) and hepatic artery perfusion (HAP) were obtained by CT Perfusion 4D software. Results The BV, BF, MTT, HAF and HAP in healthy persons were (45.7±8.4)mL/100g, (212.6±43.3)mL/min·100g, (13.5±2.3) s, (0.2±0.0) and (16.3±8.3)mL/min·100g, while in patients with Child class A were (41.0±15.3)mL/100g, (185.6±38.4)mL/min·100g,(15.2±1.2) s, (0.2±0.0) and (20.5±8.0)mL/min·100g, in patients with Child class B were (38.5±20.6)mL/100g, (126.6±90.5)mL/min·100g,(19.4±11.4) s,(0.3±0.0) and (26.7±2.0)mL/min·100g, and in with Child class C were (23.3±8.7)mL/100g, (129.4±46.6)mL/min·100g, (27.5±2.7) s, (0.4±0.1) and (35.2±12.6)mL/min·100g, respectively, showing significantly different among the four groups (P<0.05). Conclusion CT liver perfusion imaging parameters might be used to evaluate the liver functions and cirrhosis in schistosomiasis-induced liver cirrhosis, which is worthy of further investigation.

Key words: Liver cirrhosis, Schistosomiasis, Child-Pugh class, Multi-slice spiral CT scan, Perfusion imaging, Blood parameters

曾艳妮, 韩军, 刘良进, 秦涛, 毕俊英. 不同Child-Pugh分级的血吸虫病性肝硬化患者肝脏CT灌注成像参数分析[J]. 实用肝脏病杂志, 2020, 23(5): 691-694.

Zeng Yanni, Han Jun, Liu Liangjin, et al.. CT liver perfusion imaging parameters in patients with schistosomiasis-induced liver cirrhosis[J]. Journal of Practical Hepatology, 2020, 23(5): 691-694.

参考文献

[1] Djuikwo-Teukeng FF, Kouam Simo A, Allienne JF, et al. Population genetic structure of Schistosoma bovis in Cameroon. Parasite, 2019, 12(1): 56-57.
[2] 龚怡, 付倩, 张蓓. 多层螺旋CT检查肝脏体积对乙型肝炎肝硬化患者肝脏受损程度的量化诊断价值分析. 实用肝脏病杂志, 2018, 21(6): 895-898.
[3] El-Khadragy MF, Al-Olayan EM, Elmallah MIY, et al. Probiotics and yogurt modulate oxidative stress and fibrosis in livers of Schistosoma mansoni-infected mice. Comp Altern Med, 2019, 19(1): 3-4.
[4] Ma Z, Liu X, Dong H, et al. Sorafenib and praziquantel synergistically attenuate Schistosoma japonicum-induced liver fibrosis in mice. Parasite, 2018, 117(9): 2831-2839.
[5] 胡海东, 张见增. 216例肝硬化门静脉高压症患者CT血管成像门静脉侧支血管表现研究. 实用肝脏病杂志, 2016, 19(1): 73-76.
[6] Guan Bing, Li Xiao-Hong, Wang Liang,et al. Gastric fundus splenosis with hemangioma masquerading as a gastrointestinal stromal tumor in a patient with schistosomiasis and cirrhosis who underwent splenectomy: A case report and literature review. Medicine,2018, 97(27): 121-125.
[7] Koslowski N, Sombetzki M, Loebermann M, et al. Single-sex infection with female schistosoma mansoni cercariae mitigates hepatic fibrosis after secondary infection. Plo Negl Trop Dis, 2017 , 11(5): 555-556.
[8] Zheng L, Hu Y, Wang Y, et al. Recruitment of neutrophils mediated by Vγ2 γδ T cells deteriorates liver fibrosis induced by Schistosoma Japonicum infection in C57BL/6 mice. Infection, 2017, 85(8): 1020-1016.
[9] Elhenawy AA, Ashour RH, Nabih N, et al. Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma-induced liver fibrosis. Parasitol Int, 2017, 66(5): 545-554.
[10] Wang Q, Chou X, Guan F, et al. Enhanced wnt signalling in hepatocytes is associated with Schistosoma Japonicum infection and contributes to liver fibrosis. Sci Rep, 2017, 7(1): 230-231.
[11] Cascales-Campos PA, Romero PR, Schneider MA, et al. Positron emission tomography/computed tomography in patients with hepatocellular carcinoma undergoing liver transplantation. Useful, necessary or irrelevant? Eur J Radiol, 2017, 91(3): 155-159.
[12] Yun EY, Kim TH, Lee SS, et al. A Case of composite hepatocellular carcinoma and neuroendocrine carcinoma in a patient with liver cirrhosis caused by chronic hepatitis B. Kor J Gastro, 2016, 68(2): 109-113.
[13] Mu K, Zhang J, Gu Y, et al. Cord-derived mesenchymal stem cells therapy for liver cirrhosis in children with refractory Henoch-Schonlein purpura: A case report. Medicine, 2018, 97(47): 13287-13288.
[14] Agraz-Cibrián JM, Delgado-Rizo V, Segura-Ortega JE, et al. Impaired neutrophil extracellular traps and inflammatory responses in the peritoneal fluid of patients with liver cirrhosis. Scand J Imm, 2018, 88(5): 12714-12715.
[15] Abd Alla MDA, El Awady MK, Dawood RM, et al. Hepatitis C virus serologic relapse after treatment with direct-acting antivirals is dependent on viral RNA levels in peripheral blood mononuclear cells and the grade of liver cirrhosis. Arch Virol, 2018, 163(10): 2765-2774.
[16] Wen X, Yao M, Lu Y, et al. Integration of prealbumin into Child-Pugh classification improves prognosis predicting accuracy in HCC patients considering curative surgery. J Clin Transl, 2018, 6(4): 377-384.
[17] Garbuzenko DV, Arefyev NO, Kazachkov EL. Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives. Wor J Gastroenterol, 2018, 24(33): 3738-3748.
[18] Di Pascoli M1, Sacerdoti D, Pontisso P, et al. Molecular mechanisms leading to splanchnic vasodilation in liver cirrhosis. J Vasc Res, 2017, 54(2): 92-99.
[19] Talaki E, Schaffellner S, Kniepeiss D, et al. CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension? Eur Radiol, 2017, 27(10): 4173-4180.
[20] Li JP, Feng GL, Li DQ, et al. Detection and differentiation of early hepatocellular carcinoma from cirrhosis using CT perfusion in a rat liver model. Hepatobiliary Pancreat Dis Int, 2016, 15(6): 612-618.